Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended December 31, 2002 (Fiscal Year 2003)
Business Overview: McKesson operates through three primary segments: Pharmaceutical Solutions, Medical-Surgical Solutions, and Information Solutions. The company is a leading provider of healthcare products and services, including pharmaceutical distribution, medical-surgical supplies, and healthcare information technology.
Key Financial Metrics
| Metric (in millions) | Quarter Ended Dec 31, 2002 | Nine Months Ended Dec 31, 2002 |
|---|---|---|
| Total Revenues | $14,921.0 | $42,234.5 |
| Gross Profit | $727.6 | $2,217.7 |
| Operating Income | $209.8 | $634.3 |
| Net Income | $134.3 | $376.4 |
| Diluted EPS | $0.46 | $1.27 |
| Cash from Operating Activities | N/A | $357.4 |
| Cash and Equivalents (Ending) | $316.1 | $316.1 |
| Total Debt (Short-term + Long-term) | $1,331.4 | $1,331.4 |
| Debt to Capital Ratio | 22.7% | 22.7% |
Note: Total Debt includes $30.0 million short-term borrowings, $9.3 million current portion of long-term debt, and $1,292.1 million long-term debt.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 13% for the quarter and 14% for the nine-month period compared to the prior year. Growth was driven primarily by the Pharmaceutical Solutions segment (14% and 15% growth, respectively), which accounts for over 93% of consolidated revenues.
- Profitability: Net income increased 23% for the quarter and 28% for the nine-month period. Operating profit rose 14% for the quarter and 29% year-to-date.
- Segment Performance:
- Pharmaceutical Solutions: Operating profit increased 20% (quarter) and 25% (nine months) due to margin expansion and revenue growth.
- Medical-Surgical Solutions: Operating profit declined 32% for the quarter due to competitive pressures and restructuring costs, though it remained flat year-to-date.
- Information Solutions: Operating profit was flat for the quarter but increased 215% year-to-date, aided by the acquisition of A.L.I. Technologies and the reversal of customer settlement reserves.
- Working Capital: Operating working capital increased to $3,552.9 million from $3,287.3 million at the start of the fiscal year, reflecting revenue growth and inventory build-up.
Guidance, Outlook, and Risks
Management Commentary and Unusual Items
- Contract Loss Provision: The company recorded a $51.0 million provision for expected losses on five multi-year international contracts within the Information Solutions segment. This significantly impacted gross margins for the segment.
- Restructuring: Net restructuring charges were minimal for the quarter ($0.2 million) but included $12.2 million in reversals of prior year accruals year-to-date due to a revised distribution center consolidation plan. The company expects to complete consolidation plans by the end of 2003.
- Acquisitions: McKesson acquired A.L.I. Technologies Inc. for $350.7 million in July 2002, enhancing its digital medical imaging capabilities.
- Discontinued Operations: A marketing fulfillment business was sold in September 2002, resulting in an after-tax loss of $3.7 million.
Risks and Contingencies
- Legal Proceedings: Significant ongoing litigation includes shareholder class actions regarding the 1999 accounting restatement (HBOC) and ERISA claims. The company states it is not feasible to predict the outcome or potential loss range, though a material adverse impact is possible.
- Government Investigation: The U.S. Attorney's Office is investigating the marketing and Medicare reimbursement of enteral nutritional products. The company does not currently believe an adverse outcome would be material.
- Forward-Looking Risks: Risks include changes in healthcare reimbursement, customer defaults, integration challenges of acquired businesses, and the resolution of pending litigation.
Investor Verification Checklist
- Contract Losses: Verify the status and potential final cost of the $51.0 million provision for international contracts in the Information Solutions segment.
- Restructuring Progress: Monitor the completion of the distribution center consolidation plans and the realization of expected cost savings in 2004.
- Legal Exposure: Track developments in the HBOC accounting litigation and ERISA claims, as outcomes could result in substantial payments.
- Working Capital Trends: Assess the sustainability of the increase in operating working capital ($3.55 billion) and its impact on future cash flows.
- Debt Covenants: Confirm continued compliance with the debt-to-capital ratio covenant (currently 22.7% vs. 56.5% limit).